BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

SERINA THERAPEUTICS, INC.

via BRADLEY ARANT BOULT CUMMINGS LLP

3rd Quarter (July 1 - Sep 30) · 2018Posted Oct 22, 2018Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: SERINA THERAPEUTICS, INC.
Description: Pharmaceutical
Location: Alabama · United States of America

Registrant

Firm: BRADLEY ARANT BOULT CUMMINGS LLP
Description: Law firm
Location: Birmingham, Alabama, United States of America

Lobbying activities

1 issue

Health Issues
Opioids; FY19 Labor-HHS Appropriations (S. 3158, H.R. 6470, H.R. 6157), research funding
LobbyistsDAVID STEWART · PAUL KAVINOKY
Covered position (DAVID STEWART): Legislative Correspondent, Senator Jeff Sessions
Covered position (PAUL KAVINOKY): Legislative Director, Representative George Nethercutt; Deputy Chief of Staff, Representative Richard Pombo
TargetedSENATE · HOUSE OF REPRESENTATIVES · Natl Institutes of Health (NIH)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

SERINA THERAPEUTICS, INC. — Lobbying — Receipts Report